Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma

AJR. American Journal of Roentgenology
Hidenori ToyodaYasuhiro Sone

Abstract

The purpose of our study was to evaluate the impact of a unified CT angiography (CTA) system for the management of patients with hepatocellular carcinoma (HCC). A total of 1,312 patients with HCC who had been diagnosed and treated between 1990 and 2003 were studied. The clinical characteristics and survival rate were compared between patients who underwent pretreatment evaluation of tumor progression by a unified CTA system and those who underwent evaluation by a conventional angiography system. In addition, the survival rates for 438 patients who underwent transcatheter arterial chemoembolization (TACE) as initial treatment were compared between patients who were treated using a unified CTA system and those who were treated without the system. Overall, the survival rate was higher in patients who underwent pretreatment examination using a unified CTA system than in those who underwent examination without it (p < 0.0001). The survival rate was higher when focusing on patients with HCC of stage I (p = 0.0093). In patients who underwent TACE as an initial treatment, the survival rate was higher in patients treated by TACE using a unified CTA system than in those without it (p = 0.0023). The more accurate and detailed pretreatment...Continue Reading

References

Jan 1, 1985·Radiology·Y YumotoK Okuda
Jul 1, 1983·Radiology·P C Freeny, W M Marks
Jun 1, 1982·AJR. American Journal of Roentgenology·P C Freeny, W M Marks
May 11, 1995·The New England Journal of Medicine·Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixJ Rodés
Mar 11, 1999·The New England Journal of Medicine·Hashem B El-Serag, A C Mason
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G TorzilliM Makuuchi
Oct 13, 1999·Seminars in Liver Disease·Masatoshi Kudo
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Nov 19, 2003·Annals of Internal Medicine·Hashem B El-SeragKatherine A McGlynn
Aug 8, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hidenori ToyodaJunji Washizu

Citations

Oct 17, 2012·Cardiovascular and Interventional Radiology·Toshihiro TanakaAndreas H Mahnken
Jul 28, 2012·International Journal of Clinical Oncology·Yasuaki Arai
Sep 24, 2015·Cardiovascular and Interventional Radiology·Thierry de BaereMichael C Soulen
Sep 11, 2012·European Journal of Radiology·Jin IwazawaTakashi Mitani
Jul 22, 2016·Nihon Hoshasen Gijutsu Gakkai zasshi·Yoshinori Takao
Jun 22, 2019·Cardiovascular and Interventional Radiology·Lauranne PironBoris Guiu
Dec 30, 2014·World Journal of Hepatology·Norihiro ImaiHidemi Goto
Jan 5, 2021·Abdominal Radiology·Alex LionbergOsman Ahmed

Related Concepts

Arteriography
Liver Carcinoma
Malignant Neoplasm of Liver
Tomography, X-Ray Computerized Axial
Chemoembolization, Therapeutic
Spearman Rank Correlation Coefficient
Diagnosis
Tumor Progression
Evaluation
Pretreatment of Serum for Use in RBC Antibody Identification; by Differential Red Cell Absorption Using Patient RBCs or RBCs of Known Phenotype, Each Absorption

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.